Sandimmune and Ra - a phase IV clinical study of FDA data

Summary:

Ra is reported as a side effect among people who take Sandimmune (cyclosporine), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Exjade, and have Iron overload.

The phase IV clinical study analyzes which people have Ra when taking Sandimmune. It is created by eHealthMe based on reports of 6,679 people who have side effects when taking Sandimmune from the FDA, and is updated regularly.

What is Sandimmune?

Sandimmune has active ingredients of cyclosporine. eHealthMe is studying from 6,694 Sandimmune users. Check the latest studies of Sandimmune.

What is Ra?

Ra (rheumatoid arthritis) is found to be associated with 1,601 drugs and 2,113 conditions by eHealthMe. Check the latest studies of Ra.

On Jun, 17, 2026

6,679 people reported to have side effects when taking Sandimmune.
Among them, 22 people (0.33%) have Ra.

Among these 22 people:

How long have people been on Sandimmune when they have Ra? *

What is the gender of people who have Ra when taking Sandimmune? *

female: 59.09 %
male: 40.91 %

What is the age of people who have Ra when taking Sandimmune? *

What are other drugs people take besides Sandimmune? *

What are other side effects people have besides Ra? *

Joint Pain: 16 people, 72.73%
Glossodynia (a burning or painful sensation in the tongue): 14 people, 63.64%
Nausea And Vomiting: 12 people, 54.55%
Diarrhea: 12 people, 54.55%
Drug Toxicity: 12 people, 54.55%
Vitreous Detachment (a condition of the eye in which the vitreous humour separates from the retina): 11 people, 50.00%
Headache (pain in head): 11 people, 50.00%
Rashes (redness): 11 people, 50.00%
Tongue Ulceration (ulcers on tongue): 10 people, 45.45%
Photopsia (presence of perceived flashes of light): 9 people, 40.91%

What are the existing conditions these people have? *

Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 9 people, 40.91%
Iron Overload: 9 people, 40.91%
Serum Ferritin Increased: 2 people, 9.09%
Pain: 2 people, 9.09%
Oedema Peripheral (superficial swelling): 2 people, 9.09%
Herpes Virus Infection: 2 people, 9.09%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.09%
Cardiac Failure: 2 people, 9.09%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 4.55%
Neoplasm Malignant (cancer tumour): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Sandimmune and have Ra?

- Check whether Ra is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sandimmune:

Sandimmune (6,694 reports)

Ra treatments and more:

Ra (1,091,832 reports)

Browse all side effects of Sandimmune:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ra:

Ra (1,601 drugs)

Browse all the conditions that are associated with Ra:

Ra (2,113 conditions)

Related publications that referenced our studies

O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on cyclosporine (the active ingredients of Sandimmune) and Sandimmune (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.